Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes. - Wong NC; Alvim RG; Sjoberg DD; Shingarev R; Power NE; Spaliviero M; Murray KS; Benfante NE; Hakimi AA; Russo P; Coleman JA (European urology focus, 2019)